pharmaphorum July 19, 2021
Amanda Barrell

America’s biopharmaceutical industry says it is “ready to do its part” in building a stronger, more resilient, affordable, and equitable health care system for all.

COVID-19 highlighted both the challenges of the US healthcare system and the huge change potential of the country’s pharmaceutical industry.

Now, as vaccination continues at pace, the sector has pledged to help “build back better”, by lowering barriers between medical innovations and the patients who need them.

A new report by PhRMA, which represents the leading biopharmaceutical research companies in the US, said: “COVID-19 has…demonstrated that we need a healthcare system that works better for all patients, and is better prepared for future public health emergencies.

“The substantial challenges faced by states and local public...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Healthcare System, Pharma, Pharma / Biotech
Brazil’s plan for low-cost CAR-Ts
PacBio’s Repeat Expansion Panel, Owkin-Sanofi AI Take on Immunology, More
STAT+: Borrowing an idea from cancer immunotherapy, scientists make old-mice immune systems youthful again
Moderna gets Blackstone backing for flu vaccine R&D
FDA Approves Winrevair, Merck’s Novel Treatment for Pulmonary Arterial Hypertension

Share This Article